Top Markets
#1 0G 0G +34.27%
#2 Nockchain Nockchain +20.21%
#3 Fake World Assets Fake World Assets +19.15%
#4 Axelar Axelar +18.61%
#5 Full Moon Full Moon +17.70%
#6 Zora Zora +17.54%
#7 Notcoin Notcoin +16.06%
#8 Merlin's Seal BTC Merlin's Seal BTC +15.95%
#9 ADO Protocol ADO Protocol +15.57%
#10 StonkBroker StonkBroker +15.35%
Coin of the day
0G 0G
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Kyverna Therapeutics, Inc. Kyverna Therapeutics, Inc.

Kyverna Therapeutics, Inc.

KYTX
Classificação em ações #13175
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses... Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, and lupus nephritis, as well as multiple sclerosis and systemic sclerosis. The company is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing; and KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Preço da ação
$8.46
Última sincronização: 2026-08-28
Valor de mercado
$514.33M
Variação (1 dia)
-2.08%
Variação (1 ano)
128.03%
País
US
Negociar Kyverna Therapeutics, Inc. (KYTX)

Categoria

Healthcare
Histórico de dividendos de Kyverna Therapeutics, Inc. (KYTX)
Kyverna Therapeutics, Inc. (símbolo da ação: KYTX) realizou um total de 0 pagamentos de dividendos.
A soma de todos os dividendos (ajustada para desdobramentos de ações) é: 0.00
Rendimento de dividendos (TTM): 0
Pagamentos de dividendos de Kyverna Therapeutics, Inc. (KYTX) de 2026 a 2026
Pagamentos anuais de dividendos
Ano Dividendo (ajustado para desdobramentos) Alterar
Não há dados suficientes para as datas fornecidas.
Lista de todos os pagamentos de dividendos
Ano Dividendo Alterar
Não há dados suficientes para as datas fornecidas.
Dividendos de empresas semelhantes ou concorrentes
Empresa Número de pagamentos de dividendos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH